Entrega Bio

Entrega Bio

A proprietary technology that makes injectable substances available orally.

Launch date
Employees
Market cap
-
Enterprise valuation
AUD31—46m (Dealroom.co estimates Dec 2017.)
Boston Massachusetts (HQ)
  • Edit
DateInvestorsAmountRound

$4.0m

Series A

$5.0m

Early VC
Total FundingAUD13.9m

Recent News about Entrega Bio

Edit